New regimens to prevent tuberculosis in adults with HIV infection - Wikidata - awgldk - TriplyDB

New regimens to prevent tuberculosis in adults with HIV infection

New regimens to prevent tuberculosis in adults with HIV infection

http://www.wikidata.org/entity/Q36125227

about

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB The specialist physician's approach to rheumatoid arthritis in South Africa Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence Diagnosis & treatment of tuberculosis in HIV co-infected patients.Diagnosis and treatment of latent infection with Mycobacterium tuberculosis Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis Updates on the risk factors for latent tuberculosis reactivation and their managements Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America Community-Acquired Pneumonia in HIV-Positive Patients: an Update on Etiologies, Epidemiology and Management.Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru.CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.Risk factors for treatment default in close contacts with latent tuberculous infection.Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Current approaches to tuberculosis in the United States.Diagnosis and treatment of latent tuberculosis infection: an update.Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial A recent HIV diagnosis is associated with non-completion of Isoniazid Preventive Therapy in an HIV-infected cohort in Cape Town.Predicting U.S. tuberculosis case counts through 2020.House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.Tuberculosis and homelessness in Montreal: a retrospective cohort study Risk factors for developing active tuberculosis after the treatment of latent tuberculosis in adults infected with human immunodeficiency virus.Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.Viewpoint: Challenges and opportunities in tuberculosis research.Hierarchy Low CD4+/CD8+ T-Cell Counts and IFN-γ Responses in HIV-1+ Individuals Correlate with Active TB and/or M.tb Co-Infection Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention Treatment of latent tuberculosis infection in HIV: shorter or longer?Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses Current status and future prospects of epidemiology and public health training and research in the WHO African region.

P2860

Q24201325-26A43EFF-D6B4-44F4-91B9-507C8443F523 Q26765122-34C71921-A7FE-414A-8020-99A88FA92649 Q26777748-06E10299-992D-479A-BC23-417BC5F0A9E5 Q26991633-68CC9B84-AC08-4F4E-B819-DA314CF8CAE9 Q27021614-39635AD2-F1CC-4DA4-B68A-1948611ED941 Q28069032-52F16A5F-A86A-4DD3-806A-F9C732ADED2F Q28073158-7E90B325-173E-4430-B249-9D1E2558CBD9 Q28087385-98D1D116-1290-4AD2-ACA2-322FF58223D2 Q28483035-DB3DFF3D-DD4E-4394-B8E4-84718C978E0D Q28551909-DEB1B730-1DAF-4E77-BE9F-7AEEC66C9743 Q30238577-968DC302-8B54-4CD9-9E62-395DDDE79127 Q33165650-68B6A885-8E26-431A-A9F6-B95AF45E0EEE Q33585344-BB96EB15-41A2-4C49-BB18-574D8FEBDB3D Q33609582-F20CC306-BE7B-4C1F-85D8-24A47B79953D Q33618548-66CFBCBC-CD24-4D32-9AEF-C1FB50D36EDE Q33746114-4141C141-177A-4CB8-B2F6-1C62C7800852 Q33746657-6161AA2E-182D-46FC-BF18-5AB466A10A96 Q33768706-410DD739-F367-462F-98F4-0A01CE59F79F Q33790711-2DC405DE-0BF0-4BD9-BE31-3DEB40FFBD5C Q34212799-16521897-4AAF-4AD2-959E-DA6038CEA39C Q34279727-0F27002E-9083-4F0F-AF8F-711D33322AA3 Q34290177-27EE8B83-F854-4993-B132-DB3A4D0563C1 Q34499835-C58D4689-C75D-4832-B3D5-5FDCFDB02845 Q34519039-8D852C9F-11A1-4AB5-A6B0-EA6194B821EF Q34533997-9C514F09-332E-4FF4-A895-C888993CB0A8 Q34778665-0F728565-2EEF-494F-8DBC-F3B1BD2F00AC Q35001048-366AF7BF-2E2C-4FED-84B9-81FC4AB2FBAF Q35197248-FB80116A-AAE5-4AE5-8813-21FE8D725FC1 Q35567798-AD28B344-E7FC-4F30-9371-23E1C8E3F117 Q35589257-7B3330FB-CDD8-4BD7-AF78-F1F641D90B21 Q35628200-95CF4DDF-6670-42BC-B484-815370A14224 Q35775769-213736FD-ADB7-487E-AA1E-268E899E1E65 Q35818084-9B9C9207-997E-49D4-827B-84C3FB1E2E57 Q35907389-79B3D6EF-3A3E-46D9-ACCF-A633867FE792 Q35950895-BDA1689C-9076-4FD6-99F5-8E463010F37D Q36094233-5B5A34E1-6123-4C9C-90AA-B46C6C29B0A1 Q36137225-2C2E47D4-2118-419F-A35A-C1FA7EAC0AB0 Q36238015-7152E0EB-8422-46A5-8F4F-D82980400B24 Q36343641-2C7DB034-1C3F-41AC-B43C-A965B6BF4946 Q36504752-5A43A3A1-AF20-4686-BDF7-393408684D2C

P2860

New regimens to prevent tuberculosis in adults with HIV infection

http://www.wikidata.org/entity/Q36125227

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

New regimens to prevent tuberculosis in adults with HIV infection

@ast

New regimens to prevent tuberculosis in adults with HIV infection

@en

type

label

New regimens to prevent tuberculosis in adults with HIV infection

@ast

New regimens to prevent tuberculosis in adults with HIV infection

@en

prefLabel

New regimens to prevent tuberculosis in adults with HIV infection

@ast

New regimens to prevent tuberculosis in adults with HIV infection

@en

P1433

Q36125227-6F0DCC95-AF46-4E09-B6C8-9750C8A9853F

P1476

Q36125227-1305589D-82CC-4C5A-8193-A0F34E4693A7

P2093

Q36125227-04D1A2A4-B496-4B5D-B0B6-68C57589001E

Q36125227-23E374B4-3005-4CBB-82C7-837BA4BF7EFB

Q36125227-31401011-FD61-4747-B9F1-F4740C62C799

Q36125227-9A701D31-5C43-4632-BADF-4887012B1113

Q36125227-C91CD7E7-6CA5-45C2-85DA-10E483F54C6E

Q36125227-D4E27668-4B04-4AC9-838E-2B23A5D50ADB

Q36125227-F381B76A-BF2D-4D3B-9216-9BDBEECA40E7

P2860

Q36125227-2B5BAFE6-59EB-44A0-80D6-F19B7F9935A4

Q36125227-2FCB3DAB-8FE6-4C7F-8751-00FBAA686431

Q36125227-4E0A550E-0838-4CDB-8B10-9378541E7DEE

Q36125227-61318407-56CD-4035-A57F-37638B6A14F7

Q36125227-634A291B-C5CE-4832-BE3A-1FD827E47924

Q36125227-6F16C6CE-05BB-4C45-86EA-8383B453B35C

Q36125227-77A4A542-1525-4532-A65C-39DC7406B91B

Q36125227-7832C2FE-801C-4920-9BCF-0B6AE270A9E0

Q36125227-7EC553A8-B247-4C83-8F51-3CA13CF4DEB3

Q36125227-8436DEA9-B82A-48B8-8CAF-E7672E0B16C8

P304

Q36125227-817898A9-704E-4923-AA5A-2BB149E499FE

P31

Q36125227-144F9237-56CB-4A12-A79E-85020728EEB9

P356

Q36125227-A8402609-FF43-434E-9949-29A32587C5A8

P407

Q36125227-671A7625-C9CB-46EC-9507-D08584BC707C

P433

Q36125227-EE49F9F6-70EB-4030-A4F4-C7EA10EECDE4

P478

Q36125227-4F21EC00-D28B-4C0F-8FC5-B38007EA36B0

P50

Q36125227-839C7639-9EEA-4B95-9596-6FC57B008F48

Q36125227-91F871F9-1BB8-400D-963F-5741D1F0DC91

P577

Q36125227-4755DA5B-7A3B-49D2-A3A6-F31E2940C2A4

P698

Q36125227-F3354370-2CD9-46A5-ABCC-EA9011924360

P921

Q36125227-F06445D3-0566-4EA5-8B66-D1A42781AF5E

P932

Q36125227-957A127D-1F97-4735-B330-B747D143DD07

P356

P1433

The New England Journal of Medicine

P1476

New regimens to prevent tuberculosis in adults with HIV infection

@en

P2093

Glenda E Gray

http://www.w3.org/2001/XMLSchema#string

Grace L Barnes

http://www.w3.org/2001/XMLSchema#string

Harry Hausler

http://www.w3.org/2001/XMLSchema#string

James A McIntyre

http://www.w3.org/2001/XMLSchema#string

Malathi Ram

http://www.w3.org/2001/XMLSchema#string

Neil A Martinson

http://www.w3.org/2001/XMLSchema#string

Reginah Msandiwa

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of latent tuberculosis infection in HIV infected persons

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.

Isoniazid preventive therapy and risk for resistant tuberculosis.

Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

P304

11-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1005136

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P50

Lawrence H. Moulton

Richard E Chaisson

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21732833

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3407678

http://www.w3.org/2001/XMLSchema#string